Antigen Design Services
Welcome to Antigen Design Services, which is your top priority for obtaining cutting-edge solutions in the antibody therapy field. Expert scientists and researchers of Alfa Cytology are committed to providing customized antigen design services, fundamentally changing the discovery and development of targeted therapies for various diseases, including leukemia.
Introduction to Leukemia Antigen
Leukemia is cancer that affects bone marrow and hematopoietic cells, leading to abnormal production of white blood cells. Leukemia antigen refers to a specific molecule or protein found on the surface of leukemia cells or associated with leukemia. In the leukemia therapy development, it is crucial for multiple purposes to identify and understand leukemia antigens.
- Diagnosis
- Prognosis
- Monitor
- Targeted Therapy
Fig. 1. The targets and therapies for leukemia chimeric antigen receptor (CAR). (Marvin-Peek, J., et al., 2022)
With a deep understanding of the importance of antigen design in creating specific and effective antibodies, Alfa Cytology provides comprehensive services to meet your project needs. Our state-of-the-art facilities and advanced technology platform enable us to provide high-quality antigens, achieving breakthrough methods for therapeutic antibody development.
Computer Simulation
Antigen
By utilizing cutting-edge computational modeling and simulation tools and adopting reasonable design strategies, We create antigens that mimic the natural structure of the target antigen.
Chimeric Antigen
Design
Designing chimeric antigens by combining different antigen components from multiple sources. Presenting multiple epitopes has the potential to enhance the triggering of a broader immune response.
Antigen
Synthesis
Using multiple in vitro antigen expression systems, such as bacteria, yeast, insect cells, or mammalian cells. The antigen can be directly used for antibody production and screening.
Why Choose Us?
Professional
Technical
Platform
Extensive
Development
Experience
Highly
Sophisticated
Scientists
Preferential
Prices
Each project is unique and requires a personalized approach. Alfa Cytology works closely with our client to fully understand the project. Our team of scientists has extensive expertise in designing antigens to maximize the potential of successful target design, ultimately leading to more effective leukemia therapies. Contact us immediately to discuss your project or inquire about our antigen design service.
Reference
- Marvin-Peek, J.; et al. Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia. Cancers 2022, 14, 497. https://doi.org/10.3390/cancers14030497.